Insider · CIK 0001339358

Cohen Fred E

Reports to the SEC for 12 companies · BRISBANE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001339358

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-12	CDNACareDx, Inc.A Award	Director	AAward	+9,795 sh	—	—	165,060
2026-06-09	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+13.3K sh	—	—	13,300
2026-06-09	NTLAIntellia Therapeutics, Inc.A Award	Director	AAward	+9,200 sh	—	—	216,653
2026-05-27	KYTXKyverna Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20.6K sh	—	—	20,582
2026-05-27	KYTXKyverna Therapeutics, Inc.A Award	Director	AAward	+5,093 sh	—	—	21,727
2026-01-05	NTLAIntellia Therapeutics, Inc.P Purchase	Director	PPurchase	+150K sh	$9.35	+$1.4M	207,453
2025-06-13	CDNACareDx, Inc.A Award	Director	AAward	+12.1K sh	—	—	155,265
2025-06-11	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+11.5K sh	—	—	11,450
2025-06-11	NTLAIntellia Therapeutics, Inc.A Award	Director	AAward	+8,000 sh	—	—	57,453
2025-05-29	KYTXKyverna Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+65.4K sh	—	—	65,351
2025-05-29	KYTXKyverna Therapeutics, Inc.A Award	Director	AAward	+16.6K sh	—	—	16,634
2024-08-06	URGNUroGen Pharma Ltd. · Stock Option (right ot buy)A Award	Director	AAward	+10K sh	—	—	10,000
2024-06-14	CDNACareDx, Inc. · Stock Option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,048
2024-06-14	CDNACareDx, Inc.A Award	Director	AAward	+10.6K sh	—	—	143,162
2024-06-14	CDNACareDx, Inc. · Stock Option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,048
2024-06-12	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+11.5K sh	—	—	11,515
2024-06-12	NTLAIntellia Therapeutics, Inc.A Award	Director	AAward	+7,737 sh	—	—	49,453
2024-05-23	PGNYProgyny, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25.1K sh	—	—	25,070
2024-05-23	PGNYProgyny, Inc.A Award	Director	AAward	+6,176 sh	—	—	22,693
2024-02-12	KYTXKyverna Therapeutics, Inc.C Conversion	Director	CConversion	+4.52M sh	—	—	4,523,924
2024-02-12	KYTXKyverna Therapeutics, Inc. · Series A-1 Redeemable Convertible Preferred StockC Conversion	Director	CConversion	−4.4M sh	—	—	0
2024-02-12	KYTXKyverna Therapeutics, Inc. · Series A-2 Redeemable Convertible Preferred StockC Conversion	Director	CConversion	−8.83M sh	—	—	0
2024-02-12	KYTXKyverna Therapeutics, Inc. · Series B Redeemable Convertible Preferred StockC Conversion	Director	CConversion	−7.36M sh	—	—	0
2023-09-07	URGNUroGen Pharma Ltd. · Stock Option (right ot buy)A Award	Director	AAward	+10K sh	—	—	10,000
2023-07-26	URGNUroGen Pharma Ltd.A Award	Director	AAward	+69.3K sh	$9.54	+$661K	69,339
2023-06-16	CDNACareDx, Inc. · Common StockA Award	Director	AAward	+29.1K sh	—	—	29,136
2023-06-16	CDNACareDx, Inc.A Award	Director	AAward	+18.8K sh	—	—	132,592
2023-06-14	NTLAIntellia Therapeutics, Inc.A Award	Director	AAward	+4,425 sh	—	—	41,716
2023-06-14	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+6,473 sh	—	—	6,473
2023-05-24	PGNYProgyny, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18.4K sh	—	—	18,350
2023-05-24	PGNYProgyny, Inc.A Award	Director	AAward	+4,385 sh	—	—	16,517
2023-01-06	CDNACareDx, Inc.A Award	Director	AAward	+1,062 sh	—	—	113,748
2022-10-24	PGNYProgyny, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,460 sh	—	—	1,460
2022-10-24	PGNYProgyny, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15.7K sh	—	—	15,660
2022-10-24	PGNYProgyny, Inc.A Award	Director	AAward	+3,480 sh	—	—	12,132
2022-10-04	CDNACareDx, Inc.A Award	Director	AAward	+803 sh	—	—	112,686
2022-06-16	CDNACareDx, Inc.A Award	Director	AAward	+4,863 sh	—	—	111,883
2022-06-16	CDNACareDx, Inc. · Common StockA Award	Director	AAward	+7,606 sh	—	—	7,606
2022-06-14	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,688 sh	—	—	7,688
2022-06-14	NTLAIntellia Therapeutics, Inc.A Award	Director	AAward	+5,197 sh	—	—	37,291
2022-06-08	URGNUroGen Pharma Ltd. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2021-10-24	PGNYProgyny, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15.8K sh	—	—	15,831
2021-10-24	PGNYProgyny, Inc.A Award	Director	AAward	+2,652 sh	—	—	8,652
2021-06-23	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+3,382 sh	—	—	3,382
2021-06-23	NTLAIntellia Therapeutics, Inc.A Award	Director	AAward	+2,094 sh	—	—	2,094
2021-06-16	CDNACareDx, Inc. · Stock Option (right to buy)A Award	Director	AAward	+1,812 sh	—	—	1,812
2021-06-16	CDNACareDx, Inc.A Award	Director	AAward	+1,127 sh	—	—	107,020
2021-06-07	URGNUroGen Pharma Ltd. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2021-01-20	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	18,000
2021-01-20	NTLAIntellia Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$13.78	+$276K	30,000

Recent filings

Accepted (ET)
Jun 164
Cohen Fred E0001339358-26-000002
SEC(opens sec.gov)
Jun 104
Cohen Fred E0001193125-26-266233
SEC(opens sec.gov)
May 294
Cohen Fred E0001193125-26-248434
SEC(opens sec.gov)
Jan 74
Cohen Fred E0001193125-26-006288
SEC(opens sec.gov)
Jun 174
Cohen Fred E0000950170-25-087424
SEC(opens sec.gov)
Jun 134
Cohen Fred E0000950170-25-086223
SEC(opens sec.gov)
Jun 24
Cohen Fred E0000950170-25-080447
SEC(opens sec.gov)
Aug 84
Cohen Fred E0001437749-24-025298
SEC(opens sec.gov)
Jun 204/A
Cohen Fred E0000950170-24-075655
SEC(opens sec.gov)
Jun 184
Cohen Fred E0000950170-24-074946
SEC(opens sec.gov)
Jun 144
Cohen Fred E0000950170-24-073689
SEC(opens sec.gov)
May 284
Cohen Fred E0001551306-24-000109
SEC(opens sec.gov)
Feb 144
Cohen Fred E0000950170-24-015473
SEC(opens sec.gov)

Companies

Address

C/O CAREDX, INC. 8000 MARINA BOULEVARD, 4TH FLOOR

BRISBANE, CA, 94005